News

This time next year, you may be swapping your GLP-1 injections for easier and as-effective oral weight-loss medication. It's also likely to be cheaper and not suffer the same kind of supply-chain ...
The research involves a thumbnail-sized patch with micro-needles, reportedly so fine they cause no pain or pierce blood vessels, allowing painless drug delivery through skin ...
PRESS RELEASE FROM THE MINISTRY OF HEALTH AND HUMAN SERVICES Cockburn Town, Turks and Caicos Islands, 2nd May 2025: In ...
Of the total ER visits, nearly 70% involved GI issues, 15% of which led to hospitalization, according to a new study.
Obesity is in the news because of a new weight-loss drug in the form of a pill that can be taken any time of day, with or ...
A global trial finds Wegovy and Ozempic significantly improve liver health in patients and treats those with advanced fatty ...
Measles cases in the United States climbed to 939 in 29 states, the Centers for Disease Control and Prevention said Friday.
Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...
The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...
Semaglutide - the active ingredient in medications like Ozempic and WeGovy - is only FDA approved for Type-2 diabetes, but ...
Online companies marketing directly to consumers are selling naltrexone, Viagra, and Ozempic. Some studies show Ozempic ...
Wegovy to become preferred GLP-1 drug on CVS Caremark's top formularies in 2025 as Novo Nordisk expands patient access ...